Lates News

date
14/05/2025
Belite Bio (BLTE.US): The Q1 financial report for 2025 achieved a revenue of $0, compared to the previous value of $0. Earnings per share were -$0.45, compared to the previous value of -$0.33, with an expected value of -$0.37.